March News Round Up

Don't Judge this Antifibrotic Protein by the Company it Keeps

MUSC Catalyst
Dr. Carol Feghali-Bostwick says a member of a protein family known to be complicit in fibrotic diseases such as systemic sclerosis turns out instead to protect against it.

What's New on the Horizon for Scleroderma?

NIH MedlinePlus Magazine
NIH-supported expert, Dr. Carol Feghali-Bostwick reviews stem cell transplantations, anti-fibrosis drugs, and more.

Exploring the Clinical Challenges of Excessive Daytime Sleepiness (EDS) in Obstructive Sleep Apnea (OSA) Podcast

ClinicalSeriesLive
Featured speaker, Chitra Lal, M.D., D-ABSM, FCCP, FAASM, FACP, Associate Professor of Medicine, speaks on EDS and OSA in her recent podcast with Paul Doghramji, M.D., FAAFP, Medical Director, Ursinus College.

Doctor Puts on Her Dancing Shoes for a Good Cause

MUSC Catalyst
Tatsiana Beiko, M.D., MSCR, will be one of this year’s celebrity dancers at the Oxygen Ball, a “Dancing with the Stars”-style gala hosted by the American Lung Association in South Carolina. The event raises money for lung research as well as lung health programs like asthma education, lung disease support groups, smoking cessation clinics and tobacco education.

Clinical Trial at Local Charleston VA Hospital Hopes to Combat Silent Liver Disease

The Post and Courier
While many believe heavy alcohol consumption to be the sole cause of cirrhosis of the liver, at least 40 percent of the general population is suffering from what is known medically as non-alcoholic fatty liver disease. For the past few years, Dr. Wing-Kin Syn and his colleagues in gastroenterology at the Ralph H. Johnson VA Medical Center have been part of a worldwide study of a new drug treatment for the disease called elafibranor.

MUSC Health Second in World to use New Heart System

MUSC Catalyst
Dr. Jeffrey Winterfield says research shows that new mapping software does a better job than humans.